F. Mizorogi

Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects

T. Inoue, A. Ohnishi, T Inoue, 2000, Bone Marrow Transplantation.

Alcoholic cardiomyopathy--acetaldehyde poisoning rat: myocardial and serum enzyme changes in acute exposure.

T. Tanaka, M. Horiguchi, F. Mizorogi, 1983, Japanese circulation journal.

Randomized Comparison of Mobilization Kinetics of Circulating CD34+ Cells Between Biweekly CHOP and Dose-Escalated CHOP with the Prophylactic Use of Lenograstim (Glycosylated rHuG-CSF) in Aggressive Non-Hodgkin's Lymphoma

M. Ogura, K. Tobinai, N. Uike, 2000, Leukemia & lymphoma.

Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma.

T. Tanaka, Y. Takekuma, K. Takagi, 2000, Internal medicine.

The production of colony-stimulating factors by thyroid carcinoma is associated with marked neutrophilia and eosinophilia.

F. Mizorogi, H. Sato, T. Nakada, 1996, Internal medicine.

Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.

M. Taniwaki, M. Ogura, K. Tobinai, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Ultrastructural changes of intermediate filaments of hepatocyte in alcoholic liver disease.

M. Horiguchi, S. Morimoto, F. Mizorogi, 1987 .

Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301

M. Tomonaga, A. Utsunomiya, K. Itoh, 2004, International journal of hematology.